Arepo Medtech Pty Ltd · Australia
Mākoha is governance infrastructure for safe AI-enabled clinical care. Working demo live. Pharmacy wedge. Platform ambition.
demo.makoha.ai · session-gated · synthetic data only · no clinical use
Why now
Every Australian jurisdiction is expanding what a pharmacist may prescribe. In August 2026, two independent reports — from the Grattan Institute and the Sax Institute — identified significant gaps in the evidence base for pharmacist-led prescribing. The RACGP's submission to the Pharmacy Board sets out nine scenarios in which patients are harmed despite prescribing that fully complied with protocol, because protocols alone do not account for diagnostic uncertainty, follow-up, or accountability over time.
Diagnostic harm is often delayed, diffuse, and invisible to complaints-based systems.
The absence of reported harm is not the same as evidence a system is safe.
— Dr Michael Wright, RACGP President, August 2026
An industry being told it cannot prove its own safety is an industry that needs an evidence layer. That is the company.
Source: RACGP, Safety gaps exposed in pharmacy prescribing protocols, 10 August 2026.
The remedy is already specified
The RACGP's own prescription for safe pharmacist prescribing:
Care connected across episodes and sites, not one-off transactions.
A clinical history that travels with the patient.
A named professional on the record for each decision.
Diagnostic uncertainty recognised and revisited over time.
Defined routes out when the presentation exceeds scope.
Evidence that the pathway was followed, not just that a medicine was supplied.
Every item on that list is a software problem. None of them is solved by a scribe, a dispensing system, or a protocol PDF.
What Mākoha does
Accountability by design — the registered professional is never removed from the loop. Every recommendation is grounded in verifiable evidence, every output is checked before it is trusted, and every decision leaves a versioned, auditable record.
Structured history and workflow context.
Evidence, exclusions and red flags.
Human review and clinical accountability.
Longitudinal memory and audit trail.
Fail-closed — stops on missing evidence, identity mismatch or unsafe uncertainty, at every stage.
Differentiation
Australian clinicians adopt clinical AI at speed — the country's AI-scribe companies have reached tens of thousands of consultations a day and nine-figure valuations. Nobody in that cohort is solving assurance.
Note quality is matched in a release cycle. Regulatory evidence, clinical trust and cross-site audit history compound — and cannot be copied.
Source: Pharmacy Guild of Australia / Westpac, Community Pharmacy Industry Insights Report 2026. Figures dated at publication and subject to change.
Regulation-native
The TGA's guidance on AI-enabled medical device software applies from 5 February 2026: regulation is triggered by intended purpose, not technology; software as a medical device is an enforcement priority; synthetic data supplements but never replaces clinical evidence; and change control is scrutinised.
Synthetic-only development. No patient-facing release. Formal classification counsel-attested before clinical supply. Fail-closed architecture and versioned audit evidence from the first line of code.
Competitors will retrofit this. We started here — an advantage measured in years, not features.
Source: TGA, Artificial intelligence and medical device software regulation, February 2026.
Working demo · live today
The consultation surfaces run end to end at demo.makoha.ai.
The surfaces run end to end — this is working software, not a concept.
Session-controlled access, explicit prototype notice, no real patient data accepted.
The disclaimer is on the front door: educational information, not medical advice.
demo.makoha.ai · synthetic data only · no clinical use
Team
Founder · Clinician-founder · Director, Arepo Medtech Pty Ltd
Mission, product thesis and executive leadership. A practising clinician with direct experience of the Western Australian primary care, telehealth and community pharmacy landscape the product is built for.
Regulated clinical authority cannot rest on one founder. Independent authority roles are a planned milestone, gated before any live clinical activity:
Contact
Design partnership, evidence collaboration, or investment — we would like to hear from you.
Compliance and regulatory matters: compliance@arepo-tech.ai
